191480-61-2

Basic information

• Product Name: 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine
• Synonyms: 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine;(1S,2S)-N,N'-Dibenzyl-1,2-cyclohexanediamine;(1S,2S)-N,N'-Bis(phenylmethyl)-1,2-cyclohexanediamine,99%e.e.;(1S,2S)-N1,N2-Dibenzylcyclohexane-1,2-diamine
• CAS NO: 191480-61-2
• Molecular Formula: C20H26N2
• Molecular Weight: 294.43384
• Mol File: 191480-61-2.mol
• Article Data: 49

Chemical Properties

• Boiling Point: 436.3±40.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• PKA: 9.85±0.40(Predicted)
• CAS DataBase Reference: 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine(191480-61-2)
• EPA Substance Registry System: 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine(191480-61-2)

Safety Data

• Hazardous Substances Data: 191480-61-2(Hazardous Substances Data)

Usage

General Description

1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine is a chemical compound with the molecular formula C20H26N2. It is a chiral diamine with two phenylmethyl groups attached to a 1,2-cyclohexanediamine backbone. 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine has been used as a chiral ligand in various asymmetric synthesis reactions. It has also been found to exhibit biological activity as an anti-inflammatory and anti-cancer agent. The compound has potential applications in organic synthesis, pharmaceuticals, and materials science due to its chiral nature and versatile reactivity. Safety and regulatory information should be consulted when handling and using 1S,2S-N,N'-bis(phenylMethyl)-1,2-CyclohexanediaMine.

Upstream product

• 10239-34-6 N,N'-dibenzyl-1,3-diaminopropane 
• 102950-52-7 1,3-dibenzyl-2-phenyl-hexahydro-pyrimidine 
• 100-52-7 benzaldehyde 
• 694-83-7 rac-diaminocyclohexane 
• 140-28-3 N,N'-Dibenzylethylenediamine 
• 23229-37-0 1,3-dimethyl-2-phenylimidazolidine 
• 24417-01-4 7-Benzyl-7-aza-bicyclo[4.1.0]heptane 
• 100-46-9 benzylamine 
• 32044-22-7 (R,R)-1,2-diaminocyclohexane*(+)-tartric acid 
• 57707-55-8 (1R,2R)-N¹,N²-dibenzoyl-1,2-diaminocyclohexane 
• 20439-47-8 (1R,2R)-1,2-diaminocyclohexane 
• 100-39-0 benzyl bromide 
• 1043893-52-2 1,3-dibenzyl-2-phenyloctahydro-1H-benzoimidazole 
• 135613-88-6 cis/trans-N,N'-dibenzylcyclohexane-1,2-diamine 

Downstream Products

• 135614-00-5 (R,S)-(3al,7al,1'lu)-1,3-dibenzyloctahydro-2-(4',4'-dimethyl-1',2'-pentadienyl)-1H-1,3,2-benzodiazaphosphole 2-oxide 
• 135613-98-8 (R,S)-(3al,7al)-1,3-dibenzyloctahydro-2-(3'-methyl-1',2'-butadienyl)-1H-1,3,2-benzodiazaphosphole 2-oxide 
• 65838-45-1 N,N'-(cyclohexane-1,2-diyl)bis(1-phenylmethanimine) 
• 63674-16-8 N,N'-bisbenzylidene-1,3-diaminopropane 
• 4597-81-3 1,3-dibenzyl-2-phenylimidazolidine 
• 3187-82-4 (R,R)-N,N′-bis(phenylmethylene)-1,2-cyclohexanediamine 
• 23229-37-0 1,3-dimethyl-2-phenylimidazolidine 
• 1372610-45-1 (1R,2R)-N,N'-dibenzyl-N,N'-bis(ethan-(1-(S)-methyl)-1-ol)-trans-diaminocyclohexane 
• 65838-10-0 (1R,2R)-N,N'-dibenzylcyclohexane-1,2-diamine 
• 1446520-81-5 1,3-dibenzyl perhydrobenzimidazolinium chloride 
• 1430069-04-7 C₄₄H₅₆N₄O₂P₂ 
• 1429938-87-3 C₄₄H₅₆N₄O₂P₂ 
• 1430069-15-0 C₄₄H₅₆N₄O₂P₂Se₂ 

Relevant articles and documents

Machine-Assisted Preparation of a Chiral Diamine Ligand Library and In Silico Screening Using Ab Initio Structural Parameters for Heterogeneous Chiral Catalysts

A ligand library containing 31 chiral diamines was synthesized using a flow-based semiautomatic reductive amination system. These ligands were evaluated in a continuous-flow asymmetric 1,4-addition reaction with a heterogeneous Ni catalyst. Based on the experimental results of ab initio DFT calculations, a prediction model for enantioselectivities was successfully constructed. Furthermore, virtual screening of possible ligands was conducted to identify promising structures, which showed good enantioselectivities in experiments. (Figure presented.).

METAL CHELATORS FOR IMAGING, THERAPEUTICS, AND BIOANALYSIS

A variety of compounds are provided capable of chelating a metal, in particular a lanthanide such as Eu(III) and Tb(III). Luminescent complexes of the compound and a metal ion are also provided, in particular luminescent metal complexes are provided containing a lanthanide such as Eu(III) or Tb(III) and a compound described herein. In some aspects, the luminescent complexes are capable of exhibiting bright emissions with high quantum yields. Methods of making the compound are provided. Methods of using the compounds and luminescent complexes are also provided, for example for imaging and therapeutic applications.

Efficient route to pre-organized and linear polyaminopolycarboxylates: Cy-TTHA, Cy-DTPA and mono/di- reactive, tert-butyl protected TTHA/Cy-TTHA

Pre-organized polyaminopolycarboxylate chelators Cy-TTHA and Cy-DTPA were synthesized via modular five-step syntheses from commercially available starting materials in ～62% and 47% overall yields, respectively. Furthermore, strategies are reported for the efficient preparation of mono- and di-reactive, tert-butyl-protected TTHA/Cy-TTHA to selectively functionalize central chelators’ carboxylic acids.